These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2468005)

  • 21. [Immunologic defense mechanism by formation of a membrane attack complex and bacteriolysis].
    Sakai K
    Nihon Rinsho; 1988 Sep; 46(9):1962-7. PubMed ID: 3241387
    [No Abstract]   [Full Text] [Related]  

  • 22. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    Nicholson-Weller A; Burge J; Fearon DT; Weller PF; Austen KF
    J Immunol; 1982 Jul; 129(1):184-9. PubMed ID: 6211481
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and characterization of decay-accelerating factor (DAF) from Raji cells.
    Fujita T; Shinkai Y; Inoue T; Tamura N
    Immunology; 1988 Jul; 64(3):369-74. PubMed ID: 2457546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
    Lesavre P; Leibowitch J
    Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022
    [No Abstract]   [Full Text] [Related]  

  • 27. [Progress on complement protein chemistry and the molecular mechanism of activation. Standard complement pathway].
    Nagasawa S
    Nihon Rinsho; 1988 Sep; 46(9):1889-93. PubMed ID: 3241382
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT; Cooper NR; Schreiber RD
    J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT; Austen KF
    N Engl J Med; 1980 Jul; 303(5):259-63. PubMed ID: 6900901
    [No Abstract]   [Full Text] [Related]  

  • 30. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protein chemistry of the complement system].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
    [No Abstract]   [Full Text] [Related]  

  • 33. [Functions and structure of complement inactivators in membrane proteins. 2). Decay-accelerating factor].
    Sugita Y
    Nihon Rinsho; 1988 Sep; 46(9):1927-32. PubMed ID: 2468004
    [No Abstract]   [Full Text] [Related]  

  • 34. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG; Spendlove I
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
    Kazatchkine MD; Fearon DT; Austen KF
    J Immunol; 1979 Jan; 122(1):75-81. PubMed ID: 762425
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerulonephritis and complement regulatory proteins.
    Nangaku M; Johnson RJ; Couser WG
    Exp Nephrol; 1997; 5(5):345-54. PubMed ID: 9386969
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody complement-dependent bacteriolysis in experimentally induced pasteurellosis in mice.
    McVey DS; Loan RW
    Am J Vet Res; 1989 May; 50(5):762-8. PubMed ID: 2729722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic defense mechanism in the solubilization of immune complexes by complement].
    Tomooka K; Yasuda M; Nobunaga M; Sakai K
    Nihon Rinsho; 1988 Sep; 46(9):1968-73. PubMed ID: 3241388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.